Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.

Q4 Biochemistry, Genetics and Molecular Biology
Hemant Bhargav, Vidya Huilgol, Kashinath Metri, I Birgitta Sundell, Satyam Tripathi, Nagaratna Ramagouda, Mahesh Jadhav, Nagarathna Raghuram, Nagendra Hongasandra Ramarao, Prasad S Koka
{"title":"Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.","authors":"Hemant Bhargav,&nbsp;Vidya Huilgol,&nbsp;Kashinath Metri,&nbsp;I Birgitta Sundell,&nbsp;Satyam Tripathi,&nbsp;Nagaratna Ramagouda,&nbsp;Mahesh Jadhav,&nbsp;Nagarathna Raghuram,&nbsp;Nagendra Hongasandra Ramarao,&nbsp;Prasad S Koka","doi":"jsc.2012.7.3.127","DOIUrl":null,"url":null,"abstract":"<p><p>The two neighboring southwestern states of India, Karnataka and Maharashtra, have high incidence of HIV/AIDS and are among the six most high prevalence HIV infected states. In Karnataka state, the northern districts of Bagalkot, Belgaum and Bijapur (the three Bs) and in Maharashtra state, the southern districts of Sangli, Satara, and Solapur (the three Ss) are the areas with the highest incidence of HIV/AIDS. We have evaluated the incidence of maternal to child transmission (MTCT) of HIV-1 infection in Belgaum District which is more than 500 kilometers distance by road from the campus in greater Bangalore (Karnataka State). We have obtained the prenatal CD4 counts of HIV infected pregnant mothers. We have also screened the HIV infected children in two orphanages (rehabilitation centres for HIV infected children) in Belgaum District. The clinical conditions of these infected children were assessed for their CD4 counts, anti-retroviral therapy (ART) intake status, outpatient illnesses and body composition. We have observed that there is an influence of the age factor on the CD4 counts of the HIV infected children. Further, in view of the role of our recently found involvement of sulfatide, 3-O- galactosylceramide, in inhibition of HIV-1 replication and enhancement of hematopoiesis which is otherwise inhibited due to such infection, we have discussed the possible role of sulfatides that biologically occur in the fetal adnexa (placentatrophoblasts /amnion/chorion-umbilical cord), in containing HIV infection as a potential safer alternative to the ART regimens currently approved to be clinically practiced. Lastly, we have discussed the complementary and alternative medicine (CAM) therapies such as evidence based yoga and ayurveda as add-on to ART in potential elimination of MTCT of HIV infection. Out of a total of 150 children delivered by HIV infected mothers, 13 children were found to be positive as determined by the dried blood smear (DBS) for virological testing, giving an incidence of about 8.66% in the Belgaum district during the last two years, in spite of the prescription of currently available ART regimens. All the 13 HIV-transmitting mothers had normal vaginal deliveries. Though 12% of the total 150 deliveries required lower segment caesarean section (LSCS), none among them resulted in MTCT of HIV. Comparison of the prenatal CD4 counts between transmitting and non-transmitting mothers did not show significant differences (p=0.25) thus suggesting indirectly that HIV-1 proviral loads (undetermined / unavailable) need not necessarily determine the fate of incidence of vertical transmission. The mean age of 44 HIV infected children (14 females, 30 males) that were screened in two orphanages was 10.8±3.1 years. Out of these 44 children, 27 were taking ART (61.36%) with mean duration of consumption being 2.8±2.28 years. Fifty percent (n=22) of the children were suffering from at least one outpatient illness, out of which 13 were taking ART. Their mean basal metabolic rate (BMR), body mass index (BMI), muscle mass, fat mass and fat % were 795.45±106.9, 14.55±1.9 kg/m(2), 9.54±3.4 kg, 3.69±2.24 kg and 15.04±7.8% respectively. Comparison between the children taking ART (on-ART, n=27) and those not taking ART (non-ART, n= 17) showed that though there was no significant difference in the average age of the two groups, on-ART children had significantly higher BMR (p=0.05), and muscle mass (p=0.004), than non-ART. The CD4 counts, BMI, fat mass and fat percentage did not show significant statistical differences between the two groups. The CD4 counts of the children (both on-ART and non-ART) of age 8 years and below (n=12) were found to be significantly higher (p=0.04) than those of age 14 and above (n=10). All the children in age group of 14 years and above (n=10) except one child were on ART, whereas 7 out of 12 children in age group of 8 years and below were on-ART. In one of the rehabilitation centers called Aadhar, among non-ART children, a significant correlation was observed between the age of the child and CD4 counts (measured separately in the months of June 2011 and December 2011). Both the CD4 counts measured in June 2011 (n=6; r=-0.82, p= 0.04) as well as in December 2011 (n=6; r=-0.97, p=0.001) showed a significant decline as the age progressed. Also, at the same center, among on-ART children, the CD4 counts in June 2011 (n=7) and December 2011 (n=8) were significantly different between the children in the age group of 8 below years, and those in the age group of 14 years and above (p= 0.005). As HIV infected children grow in age, they may lose maternal derived immunity as shown by the decrease in CD4 counts, irrespective of their ART status. It is to be expected from these results that the conferred maternal immunity (possibly primarily humoral and secondarily cytotoxic immune responses) to the virus acquired at child birth taper off and eventually overcome by the generation of mutant HIV strains in the children, as the life spans of the infected children progress. We have discussed safer therapeutic interventions whose efficacy on HIV/AIDS may be synergistic to or even substitute the existing treatment strategies. Some of such interventions may even be customized to help eliminate MTCT. Further, these virus infected pregnant mother patient blood / serum samples could prove useful in the vaccine development against HIV infection.</p>","PeriodicalId":53626,"journal":{"name":"Journal of Stem Cells","volume":"7 3","pages":"127-53"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stem Cells","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/jsc.2012.7.3.127","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

The two neighboring southwestern states of India, Karnataka and Maharashtra, have high incidence of HIV/AIDS and are among the six most high prevalence HIV infected states. In Karnataka state, the northern districts of Bagalkot, Belgaum and Bijapur (the three Bs) and in Maharashtra state, the southern districts of Sangli, Satara, and Solapur (the three Ss) are the areas with the highest incidence of HIV/AIDS. We have evaluated the incidence of maternal to child transmission (MTCT) of HIV-1 infection in Belgaum District which is more than 500 kilometers distance by road from the campus in greater Bangalore (Karnataka State). We have obtained the prenatal CD4 counts of HIV infected pregnant mothers. We have also screened the HIV infected children in two orphanages (rehabilitation centres for HIV infected children) in Belgaum District. The clinical conditions of these infected children were assessed for their CD4 counts, anti-retroviral therapy (ART) intake status, outpatient illnesses and body composition. We have observed that there is an influence of the age factor on the CD4 counts of the HIV infected children. Further, in view of the role of our recently found involvement of sulfatide, 3-O- galactosylceramide, in inhibition of HIV-1 replication and enhancement of hematopoiesis which is otherwise inhibited due to such infection, we have discussed the possible role of sulfatides that biologically occur in the fetal adnexa (placentatrophoblasts /amnion/chorion-umbilical cord), in containing HIV infection as a potential safer alternative to the ART regimens currently approved to be clinically practiced. Lastly, we have discussed the complementary and alternative medicine (CAM) therapies such as evidence based yoga and ayurveda as add-on to ART in potential elimination of MTCT of HIV infection. Out of a total of 150 children delivered by HIV infected mothers, 13 children were found to be positive as determined by the dried blood smear (DBS) for virological testing, giving an incidence of about 8.66% in the Belgaum district during the last two years, in spite of the prescription of currently available ART regimens. All the 13 HIV-transmitting mothers had normal vaginal deliveries. Though 12% of the total 150 deliveries required lower segment caesarean section (LSCS), none among them resulted in MTCT of HIV. Comparison of the prenatal CD4 counts between transmitting and non-transmitting mothers did not show significant differences (p=0.25) thus suggesting indirectly that HIV-1 proviral loads (undetermined / unavailable) need not necessarily determine the fate of incidence of vertical transmission. The mean age of 44 HIV infected children (14 females, 30 males) that were screened in two orphanages was 10.8±3.1 years. Out of these 44 children, 27 were taking ART (61.36%) with mean duration of consumption being 2.8±2.28 years. Fifty percent (n=22) of the children were suffering from at least one outpatient illness, out of which 13 were taking ART. Their mean basal metabolic rate (BMR), body mass index (BMI), muscle mass, fat mass and fat % were 795.45±106.9, 14.55±1.9 kg/m(2), 9.54±3.4 kg, 3.69±2.24 kg and 15.04±7.8% respectively. Comparison between the children taking ART (on-ART, n=27) and those not taking ART (non-ART, n= 17) showed that though there was no significant difference in the average age of the two groups, on-ART children had significantly higher BMR (p=0.05), and muscle mass (p=0.004), than non-ART. The CD4 counts, BMI, fat mass and fat percentage did not show significant statistical differences between the two groups. The CD4 counts of the children (both on-ART and non-ART) of age 8 years and below (n=12) were found to be significantly higher (p=0.04) than those of age 14 and above (n=10). All the children in age group of 14 years and above (n=10) except one child were on ART, whereas 7 out of 12 children in age group of 8 years and below were on-ART. In one of the rehabilitation centers called Aadhar, among non-ART children, a significant correlation was observed between the age of the child and CD4 counts (measured separately in the months of June 2011 and December 2011). Both the CD4 counts measured in June 2011 (n=6; r=-0.82, p= 0.04) as well as in December 2011 (n=6; r=-0.97, p=0.001) showed a significant decline as the age progressed. Also, at the same center, among on-ART children, the CD4 counts in June 2011 (n=7) and December 2011 (n=8) were significantly different between the children in the age group of 8 below years, and those in the age group of 14 years and above (p= 0.005). As HIV infected children grow in age, they may lose maternal derived immunity as shown by the decrease in CD4 counts, irrespective of their ART status. It is to be expected from these results that the conferred maternal immunity (possibly primarily humoral and secondarily cytotoxic immune responses) to the virus acquired at child birth taper off and eventually overcome by the generation of mutant HIV strains in the children, as the life spans of the infected children progress. We have discussed safer therapeutic interventions whose efficacy on HIV/AIDS may be synergistic to or even substitute the existing treatment strategies. Some of such interventions may even be customized to help eliminate MTCT. Further, these virus infected pregnant mother patient blood / serum samples could prove useful in the vaccine development against HIV infection.

受感染儿童的年龄依赖性母亲免疫延长的证据:艾滋病毒感染的母婴传播和可能的干预措施,包括人类胎儿附件的磺胺脂和补充或替代药物。
印度西南部两个相邻的邦,卡纳塔克邦和马哈拉施特拉邦,艾滋病毒/艾滋病发病率很高,是六个艾滋病毒感染率最高的邦之一。在卡纳塔克邦,北部的巴加尔科特区、贝尔高姆区和比贾布尔区(三个b区)和马哈拉施特拉邦南部的桑利区、萨塔拉区和索拉普尔区(三个s区)是艾滋病毒/艾滋病发病率最高的地区。我们评估了Belgaum地区HIV-1感染母婴传播(MTCT)的发生率,该地区距离大班加罗尔(卡纳塔克邦)的校园有500多公里的公路距离。我们获得了感染艾滋病毒的孕妇产前CD4计数。我们还在贝尔高姆区的两所孤儿院(感染艾滋病毒儿童康复中心)对感染艾滋病毒的儿童进行了筛查。对这些受感染儿童的临床状况进行了评估,包括CD4细胞计数、抗逆转录病毒治疗(ART)摄入情况、门诊疾病和身体成分。我们观察到,年龄因素对感染艾滋病毒的儿童的CD4计数有影响。此外,鉴于我们最近发现的硫脂,3-O-半乳神经酰胺,在抑制HIV-1复制和增强因感染而被抑制的造血功能方面的作用,我们已经讨论了胎儿附件(胎盘滋养细胞/羊膜/绒毛膜-脐带)中生物发生的硫脂在抑制HIV感染方面的可能作用,作为一种潜在的更安全的替代目前已批准临床实践的抗逆转录病毒治疗方案。最后,我们讨论了补充和替代医学(CAM)疗法,如循证瑜伽和阿育吠陀,作为抗逆转录病毒治疗的补充,有可能消除母婴传播的艾滋病毒感染。在受艾滋病毒感染的母亲所生的150名儿童中,有13名儿童在进行病毒学检测时经干血涂片(DBS)检测呈阳性,在过去两年中,尽管有目前可用的抗逆转录病毒治疗方案处方,但贝尔高姆地区的发病率约为8.66%。所有13名感染艾滋病毒的母亲都是正常的阴道分娩。虽然150例分娩中有12%需要低位剖宫产(LSCS),但其中没有一例导致艾滋病毒母婴传播。传染母亲和非传染母亲的产前CD4计数比较没有显示显着差异(p=0.25),因此间接表明HIV-1前病毒载量(未确定/不可获得)不一定决定垂直传播发生率的命运。2所孤儿院筛查的44例HIV感染儿童(女14例,男30例)平均年龄为10.8±3.1岁。44例患儿中27例(61.36%)接受ART治疗,平均服药时间为2.8±2.28年。50% (n=22)的儿童患有至少一种门诊疾病,其中13人正在接受抗逆转录病毒治疗。平均基础代谢率(BMR)、体重指数(BMI)、肌肉质量、脂肪质量和脂肪%分别为795.45±106.9、14.55±1.9 kg/m(2)、9.54±3.4 kg、3.69±2.24 kg和15.04±7.8%。接受ART治疗的儿童(on-ART, n=27)与未接受ART治疗的儿童(non-ART, n= 17)比较发现,虽然两组儿童的平均年龄无显著差异,但接受ART治疗的儿童的BMR (p=0.05)和肌肉质量(p=0.004)明显高于未接受ART治疗的儿童。两组间CD4计数、BMI、脂肪量、脂肪百分比均无统计学差异。8岁及以下儿童(包括抗逆转录病毒治疗和非抗逆转录病毒治疗)的CD4计数(n=12)明显高于14岁及以上儿童(n=10) (p=0.04)。14岁及以上年龄组(n=10)除1名儿童外均接受抗逆转录病毒治疗,而8岁及以下年龄组12名儿童中有7名接受抗逆转录病毒治疗。在一家名为Aadhar的康复中心,在未接受抗逆转录病毒治疗的儿童中,观察到儿童年龄与CD4计数之间存在显著相关性(分别在2011年6月和2011年12月测量)。2011年6月测量的CD4计数(n=6;r=-0.82, p= 0.04)和2011年12月(n=6;R =-0.97, p=0.001)随着年龄的增长而显著下降。同样,在同一中心,接受抗逆转录病毒治疗的儿童中,2011年6月(n=7)和2011年12月(n=8) 8岁以下儿童和14岁及以上儿童的CD4计数差异有统计学意义(p= 0.005)。随着感染艾滋病毒的儿童年龄的增长,无论其抗逆转录病毒治疗状况如何,他们都可能失去来自母体的免疫力,CD4细胞计数的下降表明了这一点。 从这些结果可以预期,随着受感染儿童寿命的延长,在儿童出生时获得的对病毒的母体免疫(可能主要是体液免疫反应和继发性细胞毒性免疫反应)逐渐减弱,并最终被儿童体内产生的艾滋病毒突变株所克服。我们已经讨论了更安全的治疗干预措施,其对艾滋病毒/艾滋病的疗效可能与现有的治疗策略协同甚至替代。其中一些干预措施甚至可以定制,以帮助消除MTCT。此外,这些受病毒感染的孕妇患者的血液/血清样本可能对开发抗艾滋病毒感染的疫苗有用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Stem Cells
Journal of Stem Cells Medicine-Transplantation
CiteScore
0.10
自引率
0.00%
发文量
1
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信